- Home
- AGEN vs MED Comparison
AGEN vs MED Comparison
Compare AGEN & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- MED
- Stock Information
- Founded
- AGEN 1994
- MED 1980
- Country
- AGEN United States
- MED United States
- Employees
- AGEN N/A
- MED N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- MED Packaged Foods
- Sector
- AGEN Health Care
- MED Consumer Staples
- Exchange
- AGEN Nasdaq
- MED Nasdaq
- Market Cap
- AGEN 142.8M
- MED 150.7M
- IPO Year
- AGEN 2000
- MED N/A
- Fundamental
- Price
- AGEN $4.25
- MED $14.13
- Analyst Decision
- AGEN Buy
- MED Hold
- Analyst Count
- AGEN 2
- MED 1
- Target Price
- AGEN $14.50
- MED $16.50
- AVG Volume (30 Days)
- AGEN 431.2K
- MED 143.5K
- Earning Date
- AGEN 11-11-2025
- MED 11-03-2025
- Dividend Yield
- AGEN N/A
- MED N/A
- EPS Growth
- AGEN N/A
- MED N/A
- EPS
- AGEN N/A
- MED 0.33
- Revenue
- AGEN $101,706,000.00
- MED $480,449,000.00
- Revenue This Year
- AGEN $60.49
- MED N/A
- Revenue Next Year
- AGEN N/A
- MED N/A
- P/E Ratio
- AGEN N/A
- MED $42.52
- Revenue Growth
- AGEN N/A
- MED N/A
- 52 Week Low
- AGEN $1.38
- MED $11.57
- 52 Week High
- AGEN $7.34
- MED $21.98
- Technical
- Relative Strength Index (RSI)
- AGEN 45.64
- MED 54.94
- Support Level
- AGEN $3.78
- MED $13.42
- Resistance Level
- AGEN $4.38
- MED $14.06
- Average True Range (ATR)
- AGEN 0.24
- MED 0.37
- MACD
- AGEN 0.00
- MED 0.01
- Stochastic Oscillator
- AGEN 47.55
- MED 58.70
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.